PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1373917
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1373917
Uterine Cancer Therapies and Diagnostic Market, By Type, By Treatment, By Major Tests, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
REPORT HIGHLIGHT
Uterine cancer therapies and diagnostic market size was valued at USD 22,061.9 Million in 2022, expanding at a CAGR of 6.3% from 2023 to 2030.
Uterine cancer is a cancer that affects the female reproductive system. It is a malignant tumor that starts in the uterus cells and has the potential to spread to other body parts. Uterine cancer therapeutics primarily includes numerous treatment modalities, such as radiation therapy, hormone therapy, targeted therapy, chemotherapy, and surgery. Additionally, the treatment choice depends on various factors such as the patient's overall health, the type of uterine cancer, and the stage of the cancer.
Uterine Cancer Therapies and Diagnostic Market- Market Dynamics
Awareness of uterine cancer and technical innovations are expected to drive market growth
Healthcare professionals and patients are now aware of the prevalence of uterine cancer, and additionally becoming more actively interested in learning about the therapies available for the treatment of these conditions. In line with this, this is the main prominent factor for uterine cancer therapies and diagnostics in the global market. However, costly treatment procedures and adverse side effects are some of the major factors likely to hinder market growth. Furthermore, the market for uterine cancer therapies and diagnostics is being fueled by the significant increment in healthcare spending among the urban population and government initiatives for better healthcare infrastructure. Moreover, patients are being encouraged to invest in proper treatments and diagnostics as an outcome of technical innovations in healthcare services and the introduction of novel drugs regarding uterine cancer.
Uterine Cancer Therapies and Diagnostic Market- Key Insights
As per the analysis shared by our research analyst, the global uterine cancer therapies and diagnostic market is estimated to grow annually at a CAGR of around 6.3% over the forecast period (2023-2030)
The uterine cancer therapies and diagnostic industry is projected to grow at a significant rate due to the growing burden of endometrial adenocarcinoma.
Based on type segmentation, endometrial carcinomas was predicted to show maximum market share in the year 2022
Based on treatments segmentation, chemotherapy was the leading type in 2022
The prime factor responsible for the growing incidence of endometrium carcinoma is increasing obesity among women is projected to accelerate the market growth.
Uterine Cancer Therapies and Diagnostic Market- Segmentation Analysis:
The global uterine cancer therapies and diagnostic market is segmented on the basis of type, treatment, major tests, and region.
The market is divided into two categories based on type: endometrial carcinomas and uterine sarcomas. The endometrial carcinomas segment is likely to dominate the highest market share during the forecast period. One of the unique categories of uterine cancer that occurs in the lining of the uterus is endometrial carcinoma. Assessing advancements in diagnostic techniques and tools specific to endometrial carcinomas, including liquid biopsies or cutting-edge imaging technologies, offers insights into the diagnostic market within this segment.
The market is divided into five categories based on treatments: immunotherapy, surgery, chemotherapy, follow-up treatment, and radiation therapy. The chemotherapy segment is accounted to grow with the highest market share as chemotherapy is an essential component of uterine cancer treatment, particularly for metastatic or advanced cases. Chemotherapeutic substances are utilized to kill or to slow down the growth of the rapidly dividing cancer cells
Uterine Cancer Therapies and Diagnostic Market- Geographical Insights
North America is likely to dominate the uterine cancer therapeutics and diagnostics market in the future. The growing awareness and rising incidence among the general population is the prime reason for the market growth in this region. Additionally, faster adoption of new technologies in the economy is boosting the overall growth of the market studied. Moreover, the European region is accounted to dominate the market due to the changing lifestyles of women in these countries. In aged women prevalence of uterine cancer is more common.
Uterine Cancer Therapies and Diagnostic Market- Competitive Landscape:
The uterine cancer therapeutic and diagnostic market is highly competitive, with several medical device manufacturers, pharmaceutical companies, and research institutions actively participating. Advancements in diagnostic and therapeutic technologies and new entrants continue to influence the market. Additionally, for cancer treatment and screening supportive government initiatives and healthcare policies, boost the overall market growth of the uterine cancer therapeutic and diagnostic. In the field of oncology, ongoing research and development activities lead to the development of diagnostic tools and innovative therapies. For instance, in June 2023, Pfizer Inc. announced that DUAVEE® an estrogen-based menopause hormone therapy, is now back in stock in the United States, with better packaging, following a voluntary recall. The recall was due to a concern with the packaging and was not based on any safety and efficacy concerns with the product itself.
Recent Developments:
For instance, in April 2021, Roche announced the U.S. Food and Drug Administration (FDA) approval of the VENTANA MMR RxDx Panel for advanced or recurrent endometrial cancer patients. Testing can examine patients eligible for treatment with JEMPERLI (dostarlimab-gxly) monotherapy, an anti-PD1 immunotherapy from GlaxoSmithKline (GSK) that was approved by the FDA.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL UTERINE CANCER THERAPIES AND DIAGNOSTIC MARKET KEY PLAYERS
- Ariad Pharmaceuticals
- AstraZeneca PLC
- Siemens Healthcare Inc.
- Abbott Laboratories
- Eli Lilly and Company
- Becton Dickinson & co
- Roche Ltd.
- GlaxoSmithKline Plc
- Ability Pharma
- Merck & Co.
- BioMerieux S.A.
- Novartis AG
- F. Hoffmann-La Roche AG
- Sanofi
GLOBAL UTERINE CANCER THERAPIES AND DIAGNOSTIC MARKET, BY TYPE
- Endometrial carcinomas
- Uterine sarcomas
GLOBAL UTERINE CANCER THERAPIES AND DIAGNOSTIC MARKET, BY TREATMENT
- Immunotherapy
- Surgery
- Chemotherapy
- Follow-up Treatment
- Radiation therapy
GLOBAL UTERINE CANCER THERAPIES AND DIAGNOSTIC MARKET, BY MAJOR TESTS
- Hysteroscopy
- Biopsy
- Pelvic Ultrasound
- CT Scan
- Dilation and curettage
- Others
GLOBAL UTERINE CANCER THERAPIES AND DIAGNOSTIC MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Table of Contents
1. Uterine Cancer Therapies and Diagnostic Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Uterine Cancer Therapies and Diagnostic Market Snippet by Type
- 2.1.2. Uterine Cancer Therapies and Diagnostic Market Snippet by Treatment
- 2.1.3. Uterine Cancer Therapies and Diagnostic Market Snippet by Major tests
- 2.1.4. Uterine Cancer Therapies and Diagnostic Market Snippet by Country
- 2.1.5. Uterine Cancer Therapies and Diagnostic Market Snippet by Region
- 2.2. Competitive Insights
3. Uterine Cancer Therapies and Diagnostic Key Market Trends
- 3.1. Uterine Cancer Therapies and Diagnostic Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Uterine Cancer Therapies and Diagnostic Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Uterine Cancer Therapies and Diagnostic Market Opportunities
- 3.4. Uterine Cancer Therapies and Diagnostic Market Future Trends
4. Uterine Cancer Therapies and Diagnostic Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Uterine Cancer Therapies and Diagnostic Market: COVID-19 Impact Analysis
- 5.1. Pre-COVID-19 Impact Analysis
- 5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments
6. Uterine Cancer Therapies and Diagnostic Market Landscape
- 6.1. Uterine Cancer Therapies and Diagnostic Market Share Analysis, 2022
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Uterine Cancer Therapies and Diagnostic Market - By Type
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Type, 2022&2030 (%)
- 7.1.2. Endometrial carcinomas
- 7.1.3. Uterine sarcomas
8. Uterine Cancer Therapies and Diagnostic Market - By Treatment
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Treatment, 2022&2030 (%)
- 8.1.2. Immunotherapy
- 8.1.3. Surgery
- 8.1.4. Chemotherapy
- 8.1.5. Follow-up Treatment
- 8.1.6. Radiation therapy
9. Uterine Cancer Therapies and Diagnostic Market - By Major tests
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By Major tests, 2022&2030 (%)
- 9.1.2. Hysteroscopy
- 9.1.3. Biopsy
- 9.1.4. Pelvic Ultrasound
- 9.1.5. CT Scan
- 9.1.6. Dilation and curettage
10. Uterine Cancer Therapies and Diagnostic Market- By Geography
- 10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2022&2030 (%)
- 10.2. North America
- 10.2.1. Overview
- 10.2.2. Uterine Cancer Therapies and Diagnostic Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
- 10.2.7. U.S.
- 10.2.7.1. Overview
- 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.2.7.3. U.S. Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.2.7.4. U.S. Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.2.7.5. U.S. Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
- 10.2.8. Canada
- 10.2.8.1. Overview
- 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.2.8.3. Canada Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.2.8.4. Canada Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.2.8.5. Canada Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
- 10.3. Europe
- 10.3.1. Overview
- 10.3.2. Uterine Cancer Therapies and Diagnostic Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
- 10.3.7. Germany
- 10.3.7.1. Overview
- 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.7.3. Germany Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.3.7.4. Germany Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.3.7.5. Germany Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
- 10.3.8. Italy
- 10.3.8.1. Overview
- 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.8.3. Italy Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.3.8.4. Italy Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.3.8.5. Italy Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
- 10.3.9. United Kingdom
- 10.3.9.1. Overview
- 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.3.9.4. United Kingdom Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.3.9.5. United Kingdom Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
- 10.3.10. France
- 10.3.10.1. Overview
- 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.10.3. France Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.3.10.4. France Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.3.10.5. France Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
- 10.3.11. Russia
- 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.11.2. Russia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.3.11.3. Russia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.3.11.4. Russia Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
- 10.3.12. Netherlands
- 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.3.12.3. Netherlands Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.3.12.4. Netherlands Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
- 10.3.13. Sweden
- 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.13.2. Sweden Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.3.13.3. Sweden Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.3.13.4. Sweden Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
- 10.3.14. Poland
- 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.14.2. Poland Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.3.14.3. Poland Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.3.14.4. Poland Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
- 10.3.15. Rest of Europe
- 10.3.15.1. Overview
- 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.3.15.4. Rest of the Europe Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.3.15.5. Rest of the Europe Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
- 10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Uterine Cancer Therapies and Diagnostic Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
- 10.4.7. India
- 10.4.7.1. Overview
- 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.7.3. India Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.4.7.4. India Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.4.7.5. India Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
- 10.4.8. China
- 10.4.8.1. Overview
- 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.8.3. China Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.4.8.4. China Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.4.8.5. China Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
- 10.4.9. Japan
- 10.4.9.1. Overview
- 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.9.3. Japan Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.4.9.4. Japan Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.4.9.5. Japan Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
- 10.4.10. South Korea
- 10.4.10.1. Overview
- 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.10.3. South Korea Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.4.10.4. South Korea Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.4.10.5. South Korea Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
- 10.4.11. Australia
- 10.4.11.1. Overview
- 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.11.3. Australia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.4.11.4. Australia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.4.11.5. Australia Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
- 10.4.12. Thailand
- 10.4.12.1. Overview
- 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.12.3. Thailand Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.4.12.4. Thailand Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.4.12.5. Thailand Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
- 10.4.13. Indonesia
- 10.4.13.1. Overview
- 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.4.13.4. Indonesia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.4.13.5. Indonesia Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
- 10.4.14. Philippines
- 10.4.14.1. Overview
- 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.14.3. Philippines Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.4.14.4. Philippines Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.4.14.5. Philippines Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
- 10.4.15. Rest of APAC
- 10.4.15.1. Overview
- 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.4.15.4. Rest of APAC Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.4.15.5. Rest of APAC Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
- 10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Uterine Cancer Therapies and Diagnostic Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
- 10.5.7. Brazil
- 10.5.7.1. Overview
- 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.7.3. Brazil Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.5.7.4. Brazil Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.5.7.5. Brazil Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
- 10.5.8. Mexico
- 10.5.8.1. Overview
- 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.8.3. Mexico Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.5.8.4. Mexico Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.5.8.5. Mexico Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
- 10.5.9. Argentina
- 10.5.9.1. Overview
- 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.9.3. Argentina Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.5.9.4. Argentina Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.5.9.5. Argentina Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
- 10.5.10. Colombia
- 10.5.10.1. Overview
- 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.10.3. Colombia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.5.10.4. Colombia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.5.10.5. Colombia Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
- 10.5.11. Rest of LATAM
- 10.5.11.1. Overview
- 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.5.11.4. Rest of LATAM Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.5.11.5. Rest of LATAM Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
- 10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Uterine Cancer Therapies and Diagnostic Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
- 10.6.7. Saudi Arabia
- 10.6.7.1. Overview
- 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.6.7.4. Saudi Arabia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.6.7.5. Saudi Arabia Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
- 10.6.8. United Arab Emirates
- 10.6.8.1. Overview
- 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.6.8.4. United Arab Emirates Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.6.8.5. United Arab Emirates Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
- 10.6.9. Israel
- 10.6.9.1. Overview
- 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.9.3. Israel Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.6.9.4. Israel Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.6.9.5. Israel Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
- 10.6.10. Turkey
- 10.6.10.1. Overview
- 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.10.3. Turkey Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.6.10.4. Turkey Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.6.10.5. Turkey Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
- 10.6.11. Algeria
- 10.6.11.1. Overview
- 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.11.3. Algeria Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.6.11.4. Algeria Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.6.11.5. Algeria Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
- 10.6.12. Egypt
- 10.6.12.1. Overview
- 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.12.3. Egypt Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.6.12.4. Egypt Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.6.12.5. Egypt Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
- 10.6.13. Rest of MEA
- 10.6.13.1. Overview
- 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 10.6.13.4. Rest of MEA Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
- 10.6.13.5. Rest of MEA Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
11. Key Vendor Analysis- Uterine Cancer Therapies and Diagnostic Industry
- 11.1. Competitive Dashboard
- 11.2. Company Profiles
- 11.2.1. Ariad Pharmaceuticals
- 11.2.2. AstraZeneca PLC
- 11.2.3. Siemens Healthcare Inc.
- 11.2.4. Abbott Laboratories
- 11.2.5. Eli Lilly and Company
- 11.2.6. Becton Dickinson & co
- 11.2.7. Roche Ltd.
- 11.2.8. GlaxoSmithKline Plc
- 11.2.9. Ability Pharma
- 11.2.10. Merck & Co.
- 11.2.11. BioMerieux S.A.
- 11.2.12. Novartis AG
- 11.2.13. F. Hoffmann-La Roche AG
- 11.2.14. Sanofi
12. 360 Degree Analyst View
13. Appendix
- 13.1. Research Methodology
- 13.2. References
- 13.3. Abbreviations
- 13.4. Disclaimer
- 13.5. Contact Us
List of Tables
- TABLE List of data sources
- TABLE Market drivers; Impact Analysis
- TABLE Market restraints; Impact Analysis
- TABLE Uterine Cancer Therapies and Diagnostic Market: Type Snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Type
- TABLE Global Uterine Cancer Therapies and Diagnostic Market, by Type2018-2030 (USD Million)
- TABLE Uterine Cancer Therapies and Diagnostic Market: TreatmentSnapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Treatment
- TABLE Global Uterine Cancer Therapies and Diagnostic Market, by Treatment2018-2030 (USD Million)
- TABLE Uterine Cancer Therapies and Diagnostic Market: Major tests Snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Major tests
- TABLE Global Uterine Cancer Therapies and Diagnostic Market, by Major tests 2018-2030 (USD Million)
- TABLE Uterine Cancer Therapies and Diagnostic Market: Regional snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Region
- TABLE Global Uterine Cancer Therapies and Diagnostic Market, by Region 2018-2030 (USD Million)
- TABLE North America Uterine Cancer Therapies and Diagnostic Market, by Country, 2018-2030 (USD Million)
- TABLE North America Uterine Cancer Therapies and Diagnostic Market, by Type, 2018-2030 (USD Million)
- TABLE North America Uterine Cancer Therapies and Diagnostic Market, by Treatment, 2018-2030 (USD Million)
- TABLE North America Uterine Cancer Therapies and Diagnostic Market, by Major tests, 2018-2030 (USD Million)
- TABLE Europe Uterine Cancer Therapies and Diagnostic Market, by Country, 2018-2030 (USD Million)
- TABLE Europe Uterine Cancer Therapies and Diagnostic Market, by Type, 2018-2030 (USD Million)
- TABLE Europe Uterine Cancer Therapies and Diagnostic Market, by Treatment, 2018-2030 (USD Million)
- TABLE Europe Uterine Cancer Therapies and Diagnostic Market, by Major tests, 2018-2030 (USD Million)
- TABLE Asia Pacific Uterine Cancer Therapies and Diagnostic Market, by Country, 2018-2030 (USD Million)
- TABLE Asia Pacific Uterine Cancer Therapies and Diagnostic Market, by Type, 2018-2030 (USD Million)
- TABLE Asia Pacific Uterine Cancer Therapies and Diagnostic Market, by Treatment, 2018-2030 (USD Million)
- TABLE Asia Pacific Uterine Cancer Therapies and Diagnostic Market, by Major tests, 2018-2030 (USD Million)
- TABLE Latin America Uterine Cancer Therapies and Diagnostic Market, by Country, 2018-2030 (USD Million)
- TABLE Latin America Uterine Cancer Therapies and Diagnostic Market, by Type, 2018-2030 (USD Million)
- TABLE Latin America Uterine Cancer Therapies and Diagnostic Market, by Treatment, 2018-2030 (USD Million)
- TABLE Latin America Uterine Cancer Therapies and Diagnostic Market, by Major tests, 2018-2030 (USD Million)
- TABLE Middle East and Africa Uterine Cancer Therapies and Diagnostic Market, by Country, 2018-2030 (USD Million)
- TABLE Middle East and Africa Uterine Cancer Therapies and Diagnostic Market, by Type, 2018-2030 (USD Million)
- TABLE Middle East and Africa Uterine Cancer Therapies and Diagnostic Market, by Treatment, 2018-2030 (USD Million)
- TABLE Middle East and Africa Uterine Cancer Therapies and Diagnostic Market, by Major tests, 2018-2030 (USD Million)
